The importance of clinician engagement in the HTA process

About the Webinar: The slides for this webinar can be viewed at our Slideshare account.  Join Alexandra Chambers & oncologist Dr. Craig Earle with CADTH’s pan-Canadian Oncology Drug Review (pCODR) as they discuss the opportunities for clinicians to participate in the process and be part of the system, and how clinician input can help to inform

Federal pharmaceutical pricing reform: What do patients think?

About the Webinar: The slides for this webinar can be viewed at our Slideshare account.  Bill Dempster & guests Louise Binder & Martine Elias discussed the updates to the federal pharmaceutical price reform proposal, how patient leaders are responding and what steps they are taking to ensure that patients are being heard by decision makers. About the

Navigating Private Insurance in Canada

For this webinar, we’re joined by Suzanne Lepage, private health plan specialist, for a discussion of Canada’s private drug plan marketplace and its overlap with government provided services. She’ll walk us through what to expect in terms of coverage and answer audience questions about private insurance.

Clinical Trials 101

This webinar tells you what you need to know about clinical trials, their history, and helps you prepare for a trial. If you’re currently considering participating in a clinical trial, we hope that this webinar answers many of your questions. In the presentation the audience learned the difference between different types of clinical trial and the design and

What Is a Biosimilar? The Current Biologics and Biosimilars Landscape in Canada

Thursday, October 19 1:00pm – 2:00pm EST Biologic cancer treatments have become incredibly important in oncology, but they can be expensive. Biosimilars are molecules manufactured to replicate the effects of biologics. They give patients and providers a choice and help to drive prices down through competition, but doctors, patients and caregivers need to understand what

Cancer-associated blood clots webinar

This webinar introduces you to the effects of blood clots on cancer patients. This webinar also provides you with the following information: How and why blood clots effect cancer patients more than the general population Diagnosis and treatment options Resources for more information The presentation is followed by an interactive discussion with participants. Presenter Information Dr.

How Changes to the Patented Medicine Prices Review Board Could Affect Patients’ Access to Drugs

This webinar introduces you to the Patented Medicine Prices Review Board (PMPRB), how they regulate drug pricing in Canada and the proposed changes that will affect cancer patients. This webinar also provides you with the following information: Summary, analysis and next steps regarding proposed price regulation changes Patient perspectives on the proposed reforms Discussion on potential

Webinar: Unpacking the OHIP+ pharmacare plan for kids & youth in Ontario: a live webinar from the Roadmap to Optimal Access Conference

Webinar Information:  The Canadian Cancer Survivor Network is pleased to offer a special webinar titled “Unpacking the OHIP+ pharmacare plan for kids & youth in Ontario: a live webinar from CORD’s Roadmap to Optimal Access Conference”. This webinar was a live broadcast from the Canadian Organization for Rare Diseases (CORD's) Roadmap to Optimal Access event